D. Kampf

509 total citations
31 papers, 248 citations indexed

About

D. Kampf is a scholar working on Pharmacology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, D. Kampf has authored 31 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in D. Kampf's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). D. Kampf is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). D. Kampf collaborates with scholars based in Germany, United States and Switzerland. D. Kampf's co-authors include Michael Kessel, Heike Fischer, Ulrich Frei, Ralf Schindler, Ulf Teichgräber, Ivar Roots, K. Börner, Martin Schostak, Klaus Borner and Kristin Eckardt and has published in prestigious journals such as American Journal of Clinical Nutrition, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

D. Kampf

26 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Kampf Germany 10 63 53 50 46 33 31 248
Steven Kalowski Australia 10 66 1.0× 43 0.8× 52 1.0× 40 0.9× 30 0.9× 16 286
J. K. Healy Australia 9 104 1.7× 124 2.3× 29 0.6× 56 1.2× 146 4.4× 23 408
Wesley J. Alexander United States 8 18 0.3× 26 0.5× 69 1.4× 159 3.5× 44 1.3× 10 481
Roger Vanbinst Belgium 12 21 0.3× 38 0.7× 60 1.2× 94 2.0× 42 1.3× 20 367
R. M. Haslam United Kingdom 9 37 0.6× 53 1.0× 15 0.3× 32 0.7× 100 3.0× 13 354
Myung Hyun Cho South Korea 12 86 1.4× 34 0.6× 7 0.1× 61 1.3× 62 1.9× 45 263
Richard L. Simmons United States 9 19 0.3× 31 0.6× 8 0.2× 13 0.3× 52 1.6× 10 330
R. Wens Belgium 10 106 1.7× 24 0.5× 7 0.1× 17 0.4× 40 1.2× 21 305
Sadaaki Sawamura Japan 8 123 2.0× 26 0.5× 13 0.3× 16 0.3× 202 6.1× 17 458
G Riedler Switzerland 6 47 0.7× 59 1.1× 13 0.3× 23 0.5× 33 1.0× 12 298

Countries citing papers authored by D. Kampf

Since Specialization
Citations

This map shows the geographic impact of D. Kampf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Kampf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Kampf more than expected).

Fields of papers citing papers by D. Kampf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Kampf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Kampf. The network helps show where D. Kampf may publish in the future.

Co-authorship network of co-authors of D. Kampf

This figure shows the co-authorship network connecting the top 25 collaborators of D. Kampf. A scholar is included among the top collaborators of D. Kampf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Kampf. D. Kampf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kampf, D., Anja Kahl, Kai‐Uwe Eckardt, et al.. (2015). Single-Dose Kinetics of Recombinant Human Erythropoietin after Intravenous, Subcutaneous and Intraperitoneal Administration. Contributions to nephrology. 76. 106–111.
2.
Teichgräber, Ulf, et al.. (2003). Ruptured arterial aneurysm of the kidney in a patient with Wegener's granulomatosis. Nephrology Dialysis Transplantation. 18(12). 2671–2673. 24 indexed citations
3.
Oppert, Michael, Ulf C. Schneider, Wolfgang Bocksch, et al.. (2002). Improvement of left ventricular function and arterial blood pressure 1 year after simultaneous pancreas kidney transplantation. Transplantation Proceedings. 34(6). 2251–2252. 7 indexed citations
4.
Schürmann, Dirk, et al.. (2002). Domestic Cholera in Germany Associated with Fresh Fish Imported from Nigeria. European Journal of Clinical Microbiology & Infectious Diseases. 21(11). 827–828. 16 indexed citations
5.
Kahl, Andreas, Michael Oppert, A.R Müller, et al.. (2002). Sirolimus in late acute OKT3-resistant and/or steroid-resistant rejection after simultaneous pancreas and kidney transplantation. Transplantation Proceedings. 34(6). 2253–2255. 3 indexed citations
6.
Kahl, Andreas, Wolf O. Bechstein, D. Kampf, et al.. (2001). Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil. Transplantation Proceedings. 33(1-2). 1694–1695. 9 indexed citations
7.
Siegert, W., et al.. (2001). Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplantation. 27(3). 341–343. 10 indexed citations
8.
Möckel, Martin, D. Kampf, H. Lobeck, & U Frei. (1999). Severe panarteritis associated with drug abuse. Intensive Care Medicine. 25(1). 113–117. 7 indexed citations
9.
Kahl, Andreas, et al.. (1998). Complete recovery of renal function in a dialysis-dependent patient with Goodpasture syndrome.. Nephrology Dialysis Transplantation. 13(2). 462–466. 7 indexed citations
10.
Kampf, D., et al.. (1992). Pharmacokinetics of Recombinant Human Erythropoietin in Dialysis Patients after Single and Multiple Subcutaneous Administrations. ˜The œNephron journals/Nephron journals. 61(4). 393–398. 25 indexed citations
11.
Kampf, D., et al.. (1992). Multiple dose kinetics of ofloxacin and ofloxacin metabolites in haemodialysis patients. European Journal of Clinical Pharmacology. 42(1). 95–99. 7 indexed citations
12.
Kampf, D., et al.. (1991). Multiple-Dose-Kinetics of Ofloxacin after Intraperitoneal Application in CAPD Patients. Peritoneal Dialysis International. 11(4). 317–321. 5 indexed citations
13.
Kampf, D., et al.. (1990). Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis. Journal of Antimicrobial Chemotherapy. 26(suppl D). 61–68. 8 indexed citations
14.
Kampf, D., et al.. (1985). Does captopril reduce renal function in renovascular disease by postglomerular vasodilatation?. PubMed. 3(2). S139–41. 4 indexed citations
15.
Kampf, D., et al.. (1981). Effects of uremia and hemodialysis on lormetazepam disposition. Clinical Pharmacology & Therapeutics. 30(1). 77–85. 9 indexed citations
16.
Kampf, D., et al.. (1980). Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin. Antimicrobial Agents and Chemotherapy. 18(1). 81–87. 16 indexed citations
17.
Kampf, D., Ivar Roots, & Alfred G. Hildebrandt. (1980). Urinary excretion ofD-glucaric acid, an indicator of drug metabolizing enzyme activity, in patients with impaired renal function. European Journal of Clinical Pharmacology. 18(3). 255–261. 5 indexed citations
18.
Kampf, D., et al.. (1980). [The diuretic activity of bumetanide in a controlled comparison with furosemide in patients with various degrees of impaired renal function (author's transl)].. PubMed. 30(6). 1015–8. 2 indexed citations
19.
Kampf, D., et al.. (1979). HLA-antigens in systemic lupus erythematosus (SLE). Archives of Dermatological Research. 264(3). 345–350. 10 indexed citations
20.
Kampf, D., et al.. (1979). [Pharmacokinetics of azlocillin in impaired renal function and haemodialysis (author's transl)].. PubMed. 29(12a). 1944–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Kalowski Breakdown of academic impact, for papers by J. K. Healy Breakdown of academic impact, for papers by Wesley J. Alexander Breakdown of academic impact, for papers by Roger Vanbinst Breakdown of academic impact, for papers by R. M. Haslam Breakdown of academic impact, for papers by Myung Hyun Cho Breakdown of academic impact, for papers by Richard L. Simmons Breakdown of academic impact, for papers by R. Wens Breakdown of academic impact, for papers by Sadaaki Sawamura Breakdown of academic impact, for papers by G Riedler
Rankless by CCL
2026